SpineGuard Announces Full-Year 2024 Financial Results and First Quarter 2025 Sales
OrthoSpineNews
APRIL 16, 2025
PsiFGuard project co-developed with US company Omnia Medical During 2024, SpineGuard finalized the design and industrialization of its new “PsiFGuard” product intended for posterior sacroiliac joint fusion (“PSIF”). This will enable to assess their correlation with standard radiological bone density examinations.
Let's personalize your content